
Article 1 
Annex I to Directive 91/414/EEC is amended as set out in the Annex to this Directive.
Article 2 
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 30 June 2011 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
Article 3 
This Directive shall enter into force on 1 February 2011.
Article 4 
This Directive is addressed to the Member States.
Done at Brussels, 21 December 2010.
For the Commission
The President
José Manuel BARROSO
ANNEX

The following entry shall be added at the end of the table in Annex I to Directive 91/414/EEC:

No Common name, identification numbers IUPAC name Purity Entry into force Expiration of inclusion Specific provisions
‘323 BromuconazoleCAS No: 116255-48-2CIPAC No: 680 1-[(2RS,4RS:2RS,4SR)-4-bromo-2-(2,4-dichlorophenyl)tetrahydrofurfuryl]-1H-1,2,4-triazole ≥ 960 g/kg 1 February 2011 31 January 2021 
PART A Only uses as fungicide may be authorised.

PART B For the implementation of the uniform principles of Annex VI, the conclusions of the review report on bromuconazole, and in particular Appendices I and II thereof, as finalised in the Standing Committee on the Food Chain and Animal Health on 23 November 2010 shall be taken into account.
In this overall assessment, Member States shall pay particular attention to:

— operator’s safety and ensure that conditions of use prescribe the application of adequate personal protective equipment where appropriate,
— protection of aquatic organisms. Conditions of authorisation shall include risk mitigation measures, where appropriate, such as adequate buffer zones.
The Member States concerned shall ensure that the applicant presents to the Commission:

— further information on residues of triazole derivative metabolites (TDMs) in primary crops, rotational crops and products of animal origin,
— information to further address the long-term risk to herbivorous mammals.
They shall ensure that the applicant at whose request bromuconazole has been included in this Annex provides such confirmatory information to the Commission by 31 January 2013 at the latest.
The Member States concerned shall ensure that the applicant submits to the Commission further information addressing the potential endocrine disrupting properties of bromuconazole within two years after the adoption of the OECD test guidelines on endocrine disruption or, alternatively, of Community agreed test guidelines.’


